Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ADRB2 | P07550 | 1/20 | 0.41 |
| ▸ | LOXL2 | Q9Y4K0 | 6/20 | 0.40 |
| ▸ | HRH3 | Q9Y5N1 | 1/20 | 0.37 |
| ▸ | TP53 | P04637 | 3/20 | 0.37 |
| ▸ | RRM2 | P31350 | 1/20 | 0.36 |
| ▸ | NPC1 | O15118 | 3/20 | 0.35 |
| ▸ | RAB9A | P51151 | 3/20 | 0.35 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.35 |
| ▸ | PKM | P14618 | 1/20 | 0.35 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.35 |
| ▸ | ABAT | P80404 | 1/20 | 0.34 |
| ▸ | F10 | P00742 | 1/20 | 0.34 |
| ▸ | ST14 | Q9Y5Y6 | 1/20 | 0.34 |
| ▸ | CYP11B1 | P15538 | 2/20 | 0.33 |
| ▸ | CYP11B2 | P19099 | 2/20 | 0.33 |
| ▸ | CYP2A6 | P11509 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL26101758 | 0.91 | ADRB2 (0.35) | ADRB2LOXL2HRH3TP53RRM2 | |
| SCHEMBL17791755 | 0.88 | LOXL2 (0.39) | ADRB2LOXL2HRH3TP53RRM2 | |
| SCHEMBL351473 | 0.86 | LOXL2 (0.46) | ADRB2LOXL2HRH3RRM2ABAT | |
| SCHEMBL30083539 | 0.75 | CYP11B1 (0.59) | LOXL2NPC1RAB9ASMN1; SMN2CYP11B1 | |
| SCHEMBL1720975 | 0.75 | CYP11B1 (0.59) | LOXL2NPC1RAB9ASMN1; SMN2CYP11B1 | |
| SCHEMBL12486607 | 0.74 | KDM4E (0.54) | ADRB2LOXL2TP53NPC1RAB9A | |
| SCHEMBL14355099 | 0.74 | CYP11B1 (0.57) | ADRB2LOXL2CYP11B1CYP11B2CYP2A6 | |
| SCHEMBL31120747 | 0.74 | KDM4E (0.54) | ADRB2LOXL2TP53NPC1RAB9A | |
| Hydrochloric Acid SCHEMBL5010818 | 0.74 | CYP11B1 (0.57) | LOXL2NPC1RAB9ASMN1; SMN2CYP11B1 | |
| SCHEMBL19543318 | 0.72 | NPC1 (0.49) | HRH3TP53NPC1RAB9ASMN1; SMN2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230121556-A1 | COMPOUNDS FOR FAST AND EFFICIENT CLICK RELEASE | TAGWORKS PHARMACEUTICALS B.V. (NL) | 2023-04-20 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230121556-A1 | COMPOUNDS FOR FAST AND EFFICIENT CLICK RELEASE | LTB4R, LTC4S, LTA4H | ADRB2 2318/4885LOXL2 210/4885HRH3 1472/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.